Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
277
-
Total 13F shares, excl. options
-
92.1M
-
Shares change
-
-130K
-
Total reported value, excl. options
-
$2.5B
-
Value change
-
-$169M
-
Put/Call ratio
-
0.3
-
Number of buys
-
132
-
Number of sells
-
-168
-
Price
-
$27.20
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q4 2022
387 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q4 2022.
Guardant Health, Inc. - Common Stock (GH) has 277 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.1M shares
of 124M outstanding shares and own 74.34% of the company stock.
Largest 10 shareholders include FMR LLC (15.3M shares), VANGUARD GROUP INC (9.04M shares), Capital International Investors (7.85M shares), BlackRock Inc. (5.5M shares), MORGAN STANLEY (5.22M shares), VIKING GLOBAL INVESTORS LP (4.11M shares), Clearbridge Investments, LLC (2.59M shares), ALLIANCEBERNSTEIN L.P. (2.52M shares), CREDIT SUISSE AG/ (2.11M shares), and Capital Research Global Investors (2M shares).
This table shows the top 277 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.